article thumbnail

Papa’s Herb® Enters the Oregon Market Through Halo Collective

Cannabis Law Report

TORONTO , July 19, 2021 /CNW/ – Halo Collective Inc. (“Halo” or the “Company”) (NEO: HALO) (OTCQX: HCANF) (Germany: A9KN), a vertically integrated cannabis company, announced today that it has entered into a brand licensing arrangement (the “Licensing Agreement”) with Brezwald Corp. Related Links.

article thumbnail

InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

Puff Puff Post

SOURCE InMed Pharmaceuticals Inc. About InMed: InMed Pharmaceuticals is a clinical stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study Finds That Non-Pharmaceutical May Boost Quality Of Life Among Epilepsy Patients

Veriheal

Unlike “pharmaceutical CBD”—which contains zero traces of the psychoactive compound THC (tetrahydrocannabinol) and has been FDA-approved to treat Dravet syndrome and Lennox-Gastaut syndrome —artisanal CBD is non-mechanized and usually contains variable amounts of CBD and THC. It goes by the name of “artisanal CBD.” .

article thumbnail

Article – Michael Sassano CEO and Chairman Somai Pharmaceuticals: GMP Series #5: ERP Implementations

Cannabis Law Report

The ERP operates as a system, collecting data in real time and connecting it all together for your. The management of a cannabis company is very complex and needs support as more detailed. information comes available such as supplier pricing, stock changes, running costs, accounting. tables, manufacturing prices, sales prices, clients, etc.

article thumbnail

U.S. regulators plan hearing on growing use of CBD in products

Cannabis Chronicles

regulators are planning a public hearing to collect more information on CBD in cosmetics, foods and other products as the cannabis compound spreads in popularity. The FDA has approved a pharmaceutical version of CBD to treat rare seizure disorders. NEW YORK — U.S. CBD comes from marijuana or hemp plants but does not cause a high.

CBD 113
article thumbnail

Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company

Cannabis Law Report

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

article thumbnail

Thailand: Chulalongkorn University Taps into Medical Cannabis and Expands the Product Line

Cannabis Law Report

Dr. Rungpetch Sakulbumrungsilp Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University. Dr. Rungpetch Sakulbumrungsilp, Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University, unlike the present in which many facets and aspects of cannabis are being studied in addition to the work of Chula C.A.N.S.,